Issues related to implementation of the drug pricing provisions of the Inflation Reduction Act of 2022. H.R.5378 - Lower Costs, More Transparency Act - in support. S.2973 - Modernizing and Ensuring PBM Accountability Act - in support. Issues related to expanding out-of-pockets costs.

for CENTER FOR HEALTH AND DEMOCRACY · 2024 Q1

Issues related to implementation of the drug pricing provisions of the Inflation Reduction Act of 2022. H.R.4895 - Lowering Drug Costs for American Families Act - in support. H.R.485 - Protecting Health Care for All Patients Act of 2023 - opposed.

for NEW VENTURE FUND · 2024 Q1

Issues related to implementation of the drug pricing provisions of the Inflation Reduction Act of 2022.

for SOCIAL SECURITY WORKS · 2024 Q1

H.R.5378 - Lower Costs, More Transparency Act; provisions related to pharmacy beneﬁt managers.

for BLUE SHIELD OF CALIFORNIA · 2024 Q1

Prescription drug pricing generally Pharmacy Benefit Manager (PBM) reform generally S. 2973 (Modernizing and Ensuring PBM Accountability Act), all provisions S. 1339 (Pharmacy Benefit Manager Reform Act), regarding Pharmacy Benefit Manager (PBM) reform S. 3430 (Better Mental Health Care, Lower-Cost Drugs, and Extenders Act of 2023), regarding Pharmacy Benefit Manager (PBM) reform H.R. 5378 (Lower Costs, More Transparency Act), regarding Pharmacy Benefit Manager (PBM) reform H.R. 6283 (DRUG Act), regarding Pharmacy Benefit Manager (PBM) reform

for AMERICAN PHARMACY COOPERATIVE, INC. · 2024 Q1

Health-related issues including reimbursement, research, public-health & clinical care.

for CHILDREN'S NATIONAL MEDICAL CENTER · 2024 Q1

Legislation and regulation impacting outsourcing facilities regulated under Section 503B under the Federal Food, Drug, and Cosmetic Act

for QUVA PHARMA, INC. · 2024 Q1

Health Care Issues and pharmaceutical-related issues, generally; No Specific legislation during this period.

for BOESEN & SNOW, LLC · 2024 Q1